{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-004311","form_type":"8-K","ticker":"IMNN","cik":"0000749647","company_name":"Imunon, Inc.","filed_at":"2023-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.974519+00:00","generated_at":"2026-06-19T18:40:52.451378+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Imunon's EVP and CMO Nicholas Borys to depart Feb 28, 2023","bullets":["Nicholas Borys, EVP and Chief Medical Officer, will separate effective February 28, 2023.","Borys will receive salary continuation and COBRA premiums for up to 12 months; benefits cease or reduce if new employment is found.","No replacement for the CMO role has been announced at this time."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-004311","json":"https://secwatch.observer/filing/0001493152-23-004311.json","markdown":"https://secwatch.observer/filing/0001493152-23-004311.md","text":"https://secwatch.observer/filing/0001493152-23-004311.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/749647/000149315223004311/0001493152-23-004311-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/749647/000149315223004311/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T18:40:52.451378+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9b50a5c397","claim":"Nicholas Borys departed as Executive Vice President and Chief Medical Officer at Imunon, Inc..","evidence_excerpt":"On February 10, 2023, Imunon, Inc., a Delaware corporation (“Imunon”), announced that Nicholas Borys, its Executive Vice President and Chief Medical Officer, would separate from Imunon effective as of February 28, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/749647/000149315223004311/0001493152-23-004311-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"separated"},{"label":"Role","value":"Executive Vice President and Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}